Axogen, Inc. — Director's Dealing 2011

Oct 11, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AxoGen, Inc. (LECT)
CIK: 0000805928
Period of Report: 2011-09-30

Reporting Person: Harper John Frederick (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46098	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$.25	2019-07-24	Common Stock (5964)		Direct
Stock Option	$.25	2021-02-24	Common Stock (11467)		Direct
Stock Option	$1.00	2021-06-20	Common Stock (4210)		Direct
Stock Option	$1.00	2021-09-29	Common Stock (5218)		Direct

Footnotes

F1: Pursuant to an Agreement and Plan of Merger, dated as of May 31, 2011, by and among LecTec Corporation ("LecTec"), Nerve Merger Sub Corp., a subsidiary of LecTec ("Merger Sub"), and AxoGen Corporation ("AC"), which the parties amended on June 30, 2011 and August 9, 2011 (as amended, the "Merger Agreement"), Merger Sub merged with and into AC, with AC continuing after the merger as the surviving corporation and a wholly owned subsidiary of LecTec (the "Merger"). The Merger was completed on September 30, 2011, and LecTec was renamed AxoGen, Inc. ("AxoGen"). In connection with the Merger, each share of AC common stock converted into 0.03727336 share of LecTec common stock at the effective time of the Merger.

F2: In connection with the Merger, each option to purchase shares of AC common stock was converted tor an option to purchase 0.03727336 of a share of AxoGen common stock.

F3: 3,976 options have vested, and 1,988 options are unvested.

F4: None of these options have vested.

F5: These options vest annually over three years from the date of grant.